Phaseline

Targets › PRPH2

PRPH2 (Peripherin-2): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Ophthalmology; next expected readout Aug 2027.

Essential for retina photoreceptor outer segment disk morphogenesis, may also play a role with ROM1 in the maintenance of outer segment disk structure (By similarity). Required for the maintenance of retinal outer nuclear layer thickness (By similarity). (UniProt, P23942)

Open in Phaseline: the race on PRPH2, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
n-Lorem FoundationnL-PRPH2-001
Antisense oligonucleotide targeting PRPH2
PRPH2Phase 1Retinal DystrophyAug 2027

Conditions

Retinal Dystrophy (1)

Modalities

small molecule (1)

Companies

n-Lorem Foundation (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.